{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:37:43Z","timestamp":1779885463380,"version":"3.53.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.omtm.2024.101330","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T19:46:49Z","timestamp":1725047209000},"page":"101330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synergy between Lactobacillus murinus and anti-PcrV antibody delivered in the airways to boost protection against Pseudomonas aeruginosa"],"prefix":"10.1016","volume":"32","author":[{"given":"Thomas","family":"S\u00e9cher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Boisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Th\u00e9r\u00e8se","family":"Barba Goudiaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubin","family":"Pitiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Heuz\u00e9-Vourc\u2019h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2024.101330_bib1","series-title":"The burden of lung disease","year":"2016"},{"key":"10.1016\/j.omtm.2024.101330_bib2","series-title":"WHO Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed at","year":"2017"},{"key":"10.1016\/j.omtm.2024.101330_bib3","series-title":"The top 10 causes of death","year":"2020"},{"key":"10.1016\/j.omtm.2024.101330_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9020151","article-title":"Therapeutic Antibodies for the Treatment of Respiratory Tract Infections-Current Overview and Perspectives","volume":"9","author":"Mayor","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.omtm.2024.101330_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.713703","article-title":"Manipulation of the Upper Respiratory Microbiota to Reduce Incidence and Severity of Upper Respiratory Viral Infections: A Literature Review","volume":"12","author":"Nesbitt","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omtm.2024.101330_bib6","year":"2006"},{"key":"10.1016\/j.omtm.2024.101330_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13054-016-1434-y","article-title":"Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis","volume":"19","author":"Manzanares","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.omtm.2024.101330_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s40560-020-00487-8","article-title":"Efficacy of probiotics in the prevention of VAP in critically ill ICU patients: an updated systematic review and meta-analysis of randomized control trials","volume":"8","author":"Batra","year":"2020","journal-title":"J.\u00a0Intensive Care"},{"key":"10.1016\/j.omtm.2024.101330_bib9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S2213-2600(19)30140-7","article-title":"Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia","volume":"7","author":"Roquilly","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.omtm.2024.101330_bib10","article-title":"Probiotics for preventing acute upper respiratory tract infections","volume":"8","author":"Zhao","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.omtm.2024.101330_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.NAJ.0000527494.16987.1e","article-title":"Probiotics in Preventing Acute Upper Respiratory Tract Infections","volume":"117","author":"Long","year":"2017","journal-title":"Am. J. Nurs."},{"key":"10.1016\/j.omtm.2024.101330_bib12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJM196112282652601","article-title":"Bacteriologic flora of the lower\u00a0respiratory tract","volume":"265","author":"Laurenzi","year":"1961","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2024.101330_bib13","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.4049\/jimmunol.2001044","article-title":"A Pulmonary Lactobacillus murinus Strain Induces Th17 and RORgammat(+) Regulatory T\u00a0Cells and Reduces Lung Inflammation in Tuberculosis","volume":"207","author":"Bernard-Raichon","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2024.101330_bib14","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/microorganisms8081094","article-title":"Oral Primo-Colonizing Bacteria Modulate Inflammation and Gene Expression in Bronchial Epithelial Cells","volume":"8","author":"Mathieu","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.omtm.2024.101330_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1164\/rccm.201412-2316OC","article-title":"Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention. Cost-Benefit Analysis","volume":"192","author":"Branch-Elliman","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtm.2024.101330_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/0148607115621863","article-title":"Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)","volume":"40","author":"McClave","year":"2016","journal-title":"JPEN - J. Parenter. Enter. Nutr."},{"key":"10.1016\/j.omtm.2024.101330_bib17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jama.2021.13355","article-title":"Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial","volume":"326","author":"Johnstone","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.omtm.2024.101330_bib18","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s11095-011-0442-5","article-title":"The airways, a novel route for delivering monoclonal antibodies to treat lung tumors","volume":"28","author":"Maillet","year":"2011","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.omtm.2024.101330_bib19","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1517\/17425247.2015.999039","article-title":"Nebulization as a delivery method for mAbs in respiratory diseases","volume":"12","author":"Respaud","year":"2015","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.omtm.2024.101330_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2016.05.018","article-title":"Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin","volume":"234","author":"Respaud","year":"2016","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.omtm.2024.101330_bib21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jconrel.2014.10.003","article-title":"Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system","volume":"196","author":"Guilleminault","year":"2014","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.omtm.2024.101330_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2019.04.005","article-title":"In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration","volume":"303","author":"S\u00e9cher","year":"2019","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.omtm.2024.101330_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/341069","article-title":"Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV","volume":"186","author":"Frank","year":"2002","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtm.2024.101330_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-8518-1-2","article-title":"Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model","volume":"1","author":"Faure","year":"2003","journal-title":"J.\u00a0Immune Base Ther. Vaccine"},{"key":"10.1016\/j.omtm.2024.101330_bib25","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1128\/AAC.00290-15","article-title":"Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies","volume":"59","author":"Leyva-Grado","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.omtm.2024.101330_bib26","article-title":"Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters","volume":"2","author":"Piepenbrink","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.omtm.2024.101330_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2019.04.005","article-title":"In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration","volume":"303","author":"Secher","year":"2019","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.omtm.2024.101330_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00052-20","article-title":"Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Antiviral Activities and Enables Broad-Coverage Combination Therapies","volume":"94","author":"Vigil","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101330_bib29","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ismej.2016.181","article-title":"Bacteria isolated from lung modulate asthma susceptibility in mice","volume":"11","author":"Remot","year":"2017","journal-title":"ISME J."},{"key":"10.1016\/j.omtm.2024.101330_bib30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/clinids\/4.2.294","article-title":"Synergistic combinations of antibiotics in gram-negative bacillary infections","volume":"4","author":"Klastersky","year":"1982","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.omtm.2024.101330_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073396","article-title":"The Anti-Pseudomonas aeruginosa Antibody Panobacumab Is Efficacious on Acute Pneumonia in Neutropenic Mice and Has Additive Effects with Meropenem","volume":"8","author":"Secher","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2024.101330_bib32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/icb.1995.65","article-title":"Pulmonary immunity to Pseudomonas aeruginosa","volume":"73","author":"Cripps","year":"1995","journal-title":"Immunol Cell Biol."},{"key":"10.1016\/j.omtm.2024.101330_bib33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.micinf.2011.07.011","article-title":"Innate immune responses to Pseudomonas aeruginosa infection","volume":"13","author":"Lavoie","year":"2011","journal-title":"Microb. Infect."},{"key":"10.1016\/j.omtm.2024.101330_bib34","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000455857","article-title":"Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection","volume":"9","author":"Lin","year":"2017","journal-title":"J.\u00a0Innate Immun."},{"key":"10.1016\/j.omtm.2024.101330_bib35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.mucimm.2023.03.005","article-title":"Mucosal administration of anti-bacterial antibodies provide long-term cross-protection against Pseudomonas aeruginosa respiratory infection","volume":"16","author":"Pitiot","year":"2023","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.omtm.2024.101330_bib36","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1128\/CVI.00002-10","article-title":"Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in mice","volume":"17","author":"Ye","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.omtm.2024.101330_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10121530","article-title":"Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections","volume":"10","author":"Proctor","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.omtm.2024.101330_bib38","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3389\/fimmu.2018.02700","article-title":"Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract","volume":"9","author":"Domenech","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2024.101330_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206661","article-title":"Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection","volume":"13","author":"Lai\u00f1o","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2024.101330_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.116662","article-title":"Lactobacillus murinus alleviated lung inflammation induced by PAHs in mice","volume":"281","author":"Zhu","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.omtm.2024.101330_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.intimp.2013.10.020","article-title":"Lactobacillus fermentum CJL-112 protects mice against influenza virus infection by activating T-helper 1 and eliciting a protective immune response","volume":"18","author":"Yeo","year":"2014","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.omtm.2024.101330_bib42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.antiviral.2011.11.004","article-title":"Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice","volume":"93","author":"Youn","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.omtm.2024.101330_bib43","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1128\/JVI.02279-15","article-title":"Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM)","volume":"90","author":"Dyer","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101330_bib44","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1248\/bpb.23.973","article-title":"Effect of intranasal administration of Lactobacillus fermentum on the respiratory tract of mice","volume":"23","author":"Cangemi de Gutierrez","year":"2000","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.omtm.2024.101330_bib45","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/cid\/civ085","article-title":"Risk and safety of probiotics","volume":"60","author":"Doron","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.omtm.2024.101330_bib46","first-page":"1","article-title":"Safety of probiotics used to reduce risk and prevent or treat disease","volume":"200","author":"Hempel","year":"2011","journal-title":"Evid. Rep. Technol. Assess."},{"key":"10.1016\/j.omtm.2024.101330_bib47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41575-019-0111-4","article-title":"Risk assessment of probiotics use requires clinical parameters","volume":"16","author":"Langella","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtm.2024.101330_bib48","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jaci.2017.10.049","article-title":"Nasopharyngeal Lactobacillus is associated with a reduced risk of childhood wheezing illnesses following acute respiratory syncytial virus infection in infancy","volume":"142","author":"Rosas-Salazar","year":"2018","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.omtm.2024.101330_bib49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1086\/380455","article-title":"Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG","volume":"38","author":"Salminen","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.omtm.2024.101330_bib50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fmed.2016.00042","article-title":"Pneumonia and Pleural Empyema due to a Mixed Lactobacillus spp. Infection as a Possible Early Esophageal Carcinoma Signature","volume":"3","author":"Chaini","year":"2016","journal-title":"Front. Med."},{"key":"10.1016\/j.omtm.2024.101330_bib51","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1513\/AnnalsATS.201306-156MG","article-title":"Probiotics and lung immune responses","volume":"11","author":"Forsythe","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.omtm.2024.101330_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/smim.2001.0349","article-title":"Molecular mechanisms of neutrophil recruitment elicited by bacteria in the lungs","volume":"14","author":"Mizgerd","year":"2002","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.omtm.2024.101330_bib53","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/ajrccm.154.3.8810593","article-title":"Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome","volume":"154","author":"Goodman","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtm.2024.101330_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/AEM.06192-11","article-title":"Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells","volume":"78","author":"Lebeer","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.omtm.2024.101330_bib55","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/advances\/nmy063","article-title":"Mechanisms of Action of Probiotics","volume":"10","author":"Plaza-Diaz","year":"2019","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.omtm.2024.101330_bib56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrmicro.2018.12","article-title":"Microbiome: Gut microbiota sways response to cancer immunotherapy","volume":"16","author":"York","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.omtm.2024.101330_bib57","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ccell.2015.11.010","article-title":"Immunotherapy Not Working? Check Your Microbiota","volume":"28","author":"West","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omtm.2024.101330_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008072","article-title":"Lung transcriptional unresponsiveness and loss of early influenza virus control in infected neonates is prevented by intranasal Lactobacillus rhamnosus GG","volume":"15","author":"Kumova","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtm.2024.101330_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12866-021-02254-7","article-title":"Priming with intranasal lactobacilli prevents Pseudomonas aeruginosa acute pneumonia in mice","volume":"21","author":"Fangous","year":"2021","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.omtm.2024.101330_bib60","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"Vetizou","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.omtm.2024.101330_bib61","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1126\/science.aar6918","article-title":"The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies","volume":"359","author":"Zitvogel","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.omtm.2024.101330_bib62","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/2326-6066.CIR-20-0877","article-title":"Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect","volume":"9","author":"Baruch","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omtm.2024.101330_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106115","article-title":"Nasal priming with immunobiotic lactobacilli improves the adaptive immune response against influenza virus","volume":"78","author":"Tonetti","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.omtm.2024.101330_bib64","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1179\/joc.2004.16.5.437","article-title":"Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States","volume":"16","author":"Friedland","year":"2004","journal-title":"J.\u00a0Chemother."},{"key":"10.1016\/j.omtm.2024.101330_bib65","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","article-title":"Ventilator-associated pneumonia","volume":"165","author":"Chastre","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtm.2024.101330_bib66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkp201","article-title":"Update on the treatment of Pseudomonas aeruginosa pneumonia","volume":"64","author":"El Solh","year":"2009","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.omtm.2024.101330_bib67","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.chest.2018.12.008","article-title":"Epidemiology and Predictors of 30-Day Readmission in Patients With Sepsis","volume":"155","author":"Gadre","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.omtm.2024.101330_bib68","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1099\/ijsem.0.004107","article-title":"A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae","volume":"70","author":"Zheng","year":"2020","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"10.1016\/j.omtm.2024.101330_bib69","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1080\/19490976.2020.1759489","article-title":"Freeze-dried fecal samples are biologically active after long-lasting storage and suited to fecal microbiota transplantation in a preclinical murine model of Clostridioides difficile infection","volume":"11","author":"Reygner","year":"2020","journal-title":"Gut Microb."},{"key":"10.1016\/j.omtm.2024.101330_bib70","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3390\/microorganisms11112753","article-title":"A Simple In\u00a0Vitro Test to Select Stools for Fecal Microbiota Transplantation to Limit Intestinal Carriage of Extensively Drug-Resistant Bacteria","volume":"11","author":"Salandre","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.omtm.2024.101330_bib71","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.chom.2013.06.007","article-title":"Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron","volume":"14","author":"Deriu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omtm.2024.101330_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008029","article-title":"Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917","volume":"15","author":"Massip","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtm.2024.101330_bib73","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1469-0691.2005.01142.x","article-title":"Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in\u00a0vitro and in infected burns: the potential use of probiotics in wound treatment","volume":"11","author":"Vald\u00e9z","year":"2005","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T21:05:31Z","timestamp":1737666331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050124001463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2329050124001463"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101330","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergy between Lactobacillus murinus and anti-PcrV antibody delivered in the airways to boost protection against Pseudomonas aeruginosa","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101330"}}